韦纳-莫里森综合征与血管活性肠肽（VIP）。
Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
作者信息
Fahrenkrug J, Schaffalitzky de Muckadell O B
出版信息
Scand J Gastroenterol Suppl. 1979;53:57-60.
PMID:225790
Abstract
The clinical features of the Verner-Morrison syndrome are surveyed. This rare clinical entity still needs to be more clearly defined. Especially in relation to the role of VIP and the clinical value of VIP measurements. A case with a good correlation between the activity of the disease and circulating VIP is presented.
摘要
对韦纳-莫里森综合征的临床特征进行了调查。这种罕见的临床病症仍需更明确地界定。特别是在血管活性肠肽（VIP）的作用以及VIP测量的临床价值方面。本文报告了一例疾病活动与循环VIP之间具有良好相关性的病例。
Zotero 插件